CD4 and neoplasm: To test if ERG− tumor cell-associated CD4 and CD8 T-cells could represent a distinct immune cell niche, we tested a series of exhausted, cytotoxic markers55 as well as genes in the PD-1 and Reactome interferon-gamma signaling pathway (Supplementary Data 7).